Skip to content

Meet the Team

Ron_3_8x10

Ronald Berenson, MD  |  ​President and CEO

Ron Berenson, MD, is a serial entrepreneur, who has founded and served as CEO of several biomedical ventures (CellPro, Xcyte, HemaQuest, Fe3, Aequus), including two NASDAQ-listed companies. He has 30 years of experience in fundraising, business development, product development, clinical & regulatory affairs, and commercialization of medical products, including skin devices. He is a graduate of Stanford University and Yale Medical School and a former faculty member at the University of Washington.​

 

Paul_3_8x10

Paul Leung, MS, PE  |  VP of Operations

Paul has 18 years of experience in product and technology development as well as manufacturing in various industries, including several medical device companies. These include Natus Medical, Kurve Technology, Bardy Diagnostics, and Cenorin. He currently serves as the Vice President of Operations of KitoTech Medical, where he is responsible for development and manufacturing. Paul received his Bachelor of Engineering degree with Honors at Imperial College London, and a Master of Science degree at Columbia University.​

 

Eli Sonkin, Chief Financial Officer

Eli Sonkin, MBA  |  ​Chief Financial Officer

Eli leads finance and business operations at KitoTech. Before KitoTech, Eli led finance at several Seattle-based biotechnology and medical device companies, including Aequus BioPharma, Pharmain, and DMD Therapeutics. Previously, he  spent 8 years in public accounting at Deloitte & Touche and Ernst & Young.  Eli has a BA in Business Administration from the University of Washington, a Master’s in Accounting from Seattle University, and an MBA from the Haas School of Business at the University of California at Berkeley.

​

Edward Truitt, Chairman of the Board

Edward R. Truitt, III, JD  |  ​Chairman of the Board

Ed is a life sciences entrepreneur, investor and board member. He is CEO of Lubris BioPharma, which is developing a therapeutic protein for dry eye and inflammation-related conditions. Lubris sold its ophthalmology portfolio to Novartis. Mr. Truitt is co-founder of Biological Dynamics, a developer of oncology diagnostics and he serves on the Board of Sound Life Sciences.  Previously, Mr. Truitt practiced corporate law, focusing on business formation and technology licensing. Mr. Truitt received his JD from University of San Diego and BA from UC Santa Barbara.